Literature DB >> 6729256

Acute effect of inhaled salbutamol on mucociliary clearance in health and chronic bronchitis.

C L Lafortuna, F Fazio.   

Abstract

We investigated in a double-blind study the acute effect of the inhaled beta 2-adrenergic agent salbutamol on mucociliary clearance in man. Subjects were 20 patients with chronic bronchitis (10 receiving the drug and 10 placebo) and 6 healthy individuals (3 receiving the drug and 3 placebo). Mucociliary clearance was evaluated after inhalation of a pressurized 99mTc-labelled a albumin aerosol (median mass aerodynamic diameter 2.85 microns). Particle deposition and clearance was determined by external recording with a large-field gamma camera and dedicated computer, for three consecutive hours without moving the subject. After 1 h baseline clearance recording the subject was given either salbutamol (500 micrograms) or vehicle alone from a commercial pressurized nebulizer; recording was then continued for a further 2 h (test period). Both patients and normals treated with salbutamol showed a significant increase in the rate of clearance when compared with their respective control group receiving placebo. Clearance rates (percentage activity cleared per hour) from the lungs in the hour after salbutamol inhalation averaged 33.1% +/- 13.5 (SD) per hour, for patients (control 12.2% +/- 5.6 (SD) per hour, p less than 0.001) and 16.1% +/- 4.3 (SD) per hour for normals (control 7.8% +/- 2.0 (SD) per hour, (p less than 0.005). Significant differences were also found in clearance rate before and after salbutamol inhalation in both treated groups. Cough events did not produce any significant effect on average mucociliary clearance. However, visualization of serial computer images in individual patients showed that cough may generate appreciable upward, downward or even lung-to-lung movements of radioactive boli.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6729256     DOI: 10.1159/000194607

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  9 in total

1.  Imaging of the airways by bronchoscintigraphy for the study of mucociliary clearance.

Authors:  S Groth; J Mortensen; P Lange; E P Munch; P G Sørensen; N Rossing
Journal:  Thorax       Date:  1988-05       Impact factor: 9.139

Review 2.  Salbutamol in the 1980s. A reappraisal of its clinical efficacy.

Authors:  A H Price; S P Clissold
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

Review 3.  Cilia dysfunction in lung disease.

Authors:  Ann E Tilley; Matthew S Walters; Renat Shaykhiev; Ronald G Crystal
Journal:  Annu Rev Physiol       Date:  2014-10-29       Impact factor: 19.318

4.  Treatment of chronic bronchitis with terbutaline inhaled from a cone spacer with and without positive expiratory pressure.

Authors:  E F Christensen; R Dahl
Journal:  Lung       Date:  1991       Impact factor: 2.584

5.  Effect of terbutaline on mucociliary clearance in asthmatic and healthy subjects after inhalation from a pressurised inhaler and a dry powder inhaler.

Authors:  J Mortensen; S Groth; P Lange; F Hermansen
Journal:  Thorax       Date:  1991-11       Impact factor: 9.139

Review 6.  Clinical review: airway hygiene in the intensive care unit.

Authors:  Sanja Jelic; Jennifer A Cunningham; Phillip Factor
Journal:  Crit Care       Date:  2008-03-31       Impact factor: 9.097

7.  Buried under gypsum powder - A rare respiratory complication.

Authors:  P Brun; A Kunz; M Funke
Journal:  Respir Med Case Rep       Date:  2013-02-04

Review 8.  Mucociliary dysfunction in HIV and smoked substance abuse.

Authors:  Srinivasan Chinnapaiyan; Hoshang J Unwalla
Journal:  Front Microbiol       Date:  2015-10-14       Impact factor: 5.640

9.  A Neutralizing Aptamer to TGFBR2 and miR-145 Antagonism Rescue Cigarette Smoke- and TGF-β-Mediated CFTR Expression.

Authors:  Rajib K Dutta; Srinivasan Chinnapaiyan; Lawrence Rasmussen; S Vamsee Raju; Hoshang J Unwalla
Journal:  Mol Ther       Date:  2018-12-06       Impact factor: 11.454

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.